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Endothelial Cell Autonomous Role of Akt1
Regulation of Vascular Tone and Ischemia-Induced Arteriogenesis
Monica Y. Lee, Ana Gamez-Mendez, Jiasheng Zhang, Zhenwu Zhuang, David J. Vinyard,
Jan Kraehling, Heino Velazquez, Gary W. Brudvig, Themis R. Kyriakides, Michael Simons,
William C. Sessa
Objective—The importance of PI3K/Akt signaling in the vasculature has been demonstrated in several models, as global loss of
Akt1 results in impaired postnatal ischemia- and VEGF-induced angiogenesis. The ubiquitous expression of Akt1, however,
raises the possibility of cell-type–dependent Akt1-driven actions, thereby necessitating tissue-specific characterization.
Approach and Results—Herein, we used an inducible, endothelial-specific Akt1-deleted adult mouse model (Akt1iECKO)
to characterize the endothelial cell autonomous functions of Akt1 in the vascular system. Endothelial-targeted ablation of
Akt1 reduces eNOS (endothelial nitric oxide synthase) phosphorylation and promotes both increased vascular contractility
in isolated vessels and elevated diastolic blood pressures throughout the diurnal cycle in vivo. Furthermore, Akt1iECKO
mice subject to the hindlimb ischemia model display impaired blood flow and decreased arteriogenesis.
Conclusions—Endothelial Akt1 signaling is necessary for ischemic resolution post-injury and likely reflects the consequence
of NO insufficiency critical for vascular repair.
Visual Overview—An online visual overview is available for this article.   (Arterioscler Thromb Vasc Biol. 2018;38:
870-879. DOI: 10.1161/ATVBAHA.118.310748.)
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itric oxide (NO) is an important mediator of cardiovascular homeostasis through its ability to exert physiological
effects on numerous cells types of the vasculature. NO coordinates several biological functions, including blood flow,
proportional vascular remodeling, and angiogenesis. In the
endothelium, NO is primarily generated through eNOS (endothelial nitric oxide synthase) in response to local agonists (ie,
bradykinin, acetylcholine) and alterations in hemodynamics.
NO can subsequently diffuse through the plasma membrane
to the underlying vascular smooth muscle layer to regulate
cGMP-dependent vascular relaxation and systemic blood
pressure. Enzyme activity is also essential for NO diffusion
into the lumen, where binding to hemoglobin in erythrocytes
provides circulating NO bioequivalents.
The in vivo regulation of eNOS is a complex process that
involves multiple interdependent control mechanisms such
as lipidation, subcellular localization, intracellular calcium,
substrate availability, and phosphorylation at key activation
sites, namely serine 1177 (in human eNOS; mouse: S1176;
bovine: S1179).1,2 Phosphorylation of eNOS at S1177 has
previously been shown to occur at low levels of intracellular calcium (ie, with shear stress, insulin),3,4 highlighting the

various avenues of eNOS activation. Although several kinases
have been identified for eNOS-S1177 phosphorylation (ie,
PKA, AMPK),5 S1177 phosphorylation occurs in vivo predominantly through Akt.6 The protein kinase Akt is a major
hub for several signal transduction pathways through its ability to phosphorylate numerous downstream targets directly
involved in various cellular processes including proliferation, cell survival, and metabolism—all critical for vascular remodeling.7,8 Akt has also been shown to preferentially
phosphorylate the eNOS isoform over other NOS isoforms,
as cotransfection of Akt with nNOS and iNOS does not
induce NO release.4 Biochemical approaches validate S1176
phosphorylation as the main activation site in intact cells, as a
loss-of-function mutation to alanine (S1176A) abolishes Aktdependent eNOS phosphorylation and reduces NO release.
Similarly, a gain-of-function mutation to mimic phosphorylation (S1176D) results in significantly enhanced in vitro eNOS
enzyme activity.3,4 We have additionally shown the functional
importance of S1176 phosphorylation in vasomotor tone regulation, as S1179D adenoviral delivery restores endothelial
cell (EC)–dependent vasodilatory responses in pressurized
arteries from eNOS knockout mice.9 Furthermore, genetic
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knockin approaches indicate that Akt1 is the primary kinase
for eNOS in vivo, as introduction of the S1176D phosphomimic mutation in global Akt1 knockout mice rescues the
profound defects in revascularization after hindlimb ischemia
(HLI) and wounding these mice.6
Of the 3 Akt isoforms (Akt1/Akt2/Akt3), ECs express predominantly Akt1, the major isoform involved in the regulation of cardiovascular function.10–13 We have previously shown
the isoform-dependent role of Akt in vascular remodeling,
as ischemic limb repair is severely impaired in global Akt1
knockout mice.10 Unlike the pronounced defects seen in Akt1
knockout mice on injury, global Akt2 knockout mice display
normal hindlimb flow recovery, paralleling the in vitro observation of preferential eNOS-S1177 phosphorylation through
the Akt1 isoform when compared with the Akt2 isoform.10,11
On a whole organism level, however, global loss of Akt1
results in severe growth defects both in utero and postnatal
life, as Akt1KO mice remain smaller than average throughout
adulthood.14,15 The obvious growth retardation together with
the increased propensity to apoptosis in global Akt1 knockout
mice thus limits the interpretation of how the Akt1 isoform
regulates adult vascular remodeling. Furthermore, the protein
kinase Akt1 is positioned as a key signaling intermediate in all
cell types, thereby confounding theoretical predictions as to
the tissue-specific role of Akt1.
Here, we use an inducible, endothelial-specific Akt1-null
adult mouse model (Akt1iECKO) to address the EC-specific,
postnatal role of Akt1 in vivo. Akt1iECKO mice display phenotypes indicative of impaired eNOS function and consequent
endothelial dysfunction. We show that endothelial Akt1 ablation promotes a spontaneous hypertensive phenotype associated with EC dysfunction. Furthermore, Akt1iECKO mice
subject to HLI display diminished blood flow recovery where
micro-CT imaging indicates an associated impairment of arteriogenesis. Collectively, the cardiovascular phenotypes that
arise because of the postnatal deletion of Akt1 in EC support
the critical role of the Akt–eNOS signaling axis in the regulation of vascular function in vivo.

Materials and Methods
Inducible Endothelial-Specific
Akt1 Conditional Mice

NO Bioavailability (Electric
Paramagnetic Resonance)
Electric paramagnetic resonance was applied to measure hemoglobinbound NO (Hb-NO) in whole blood, as previously described.18 In brief,
mice were euthanized by CO2 inhalation for subsequent blood isolation
from the inferior vena cava. Samples were immediately flash-frozen
in liquid N2 for later spectrometer analysis. Mice harboring germline
eNOS knockin mutations (S1176D+/+ and S1176A+/+)6 and lacking
eNOS19 were used as gating controls for Hb-NO signal detection. All
mice were given standard chow to ensure fixed levels of nitrate/nitrite
content to prevent dietary influences on NO bioavailability.

Wire Myography
Wire myography was performed, as previously described.20 Thoracic
aortas were isolated and cleaned under a dissecting scope to remove
residual fat and connective tissues. Aortic rings of uniform length
were suspended using 2 tungsten wires through the lumen and subsequently mounted onto myograph chambers containing Krebs buffer
solution (95% O2/5% CO2, 37°C). Aortic rings were set to a resting
tension of 1.5 g under isometric conditions and allowed to equilibrate.
After equilibration, aortic rings were subject to several rounds of KCl
contraction followed by contractile-induced dose–response curves.
For relaxation studies, aortic rings were pre-constricted to ≈80%
maximal constriction before acetylcholine dose-curve generation.
Increasing concentrations of the desired agents were administered at
half-log increments where real-time responses were recorded using
Chart5 (AD Instruments). Control and Akti1ECKO aortic rings were
studied simultaneously, isolating at least 3 to 4 aortic rings per mouse.
Tension–response curve data reflect a nonlinear regression curve (log
[agonist] versus response) using Prism 6.0 (GraphPad Software).

Blood Pressure Telemetry
Radiotelemetric blood pressure catheters were implanted in the right
carotid artery of adult male (10–12 weeks old) mice and allowed to
recover 1 week from surgery, as previously described.21,22 Mice were
housed in individually controlled environments with a 12-hour light/
dark cycle with free access to food and water. Parameters of interest were measured at 1-minute intervals for 7 consecutive days. Data
reflect averaged values over a 3-day reading period.

Hindlimb Ischemia

The Akt1
were bred to the Cdh5-Cre-ERT2 mice to obtain
inducible, endothelial-targeted Akt1 mice, as previously described.11
Young adult, male mice (≈4–5 weeks of age) were injected with
tamoxifen (100 μg/g total body weight) via intraperitoneal delivery
for 7 consecutive days. Phenotyping assessments were performed 6
weeks post-tamoxifen administration (≈10–12 weeks of age).
flox/flox16

Thoracic aortas were isolated from control and Akt1iECKO immediately after euthanize. Aortas (or indicated arteries) were isolated
and cut longitudinally for en face immunostaining. The isolated tissues were incubated at 37°C in serum-free base media for ≈4 hours
before ex vivo treatment with Ang1 (angiopoietin-1; 500 ng/mL) or
PDGF (platelet-derived growth factor)-BB (50 ng/mL) for the indicated times. Samples were then fixed in 4% PFA/PBS and permeabilized overnight in TNB blocking buffer (0.1 mol/L Tris pH 7.4, 150
mmol/L NaCl, 0.2% Triton-X-100, 0.5% blocking reagent) for wholemount analysis. Aortas were stained with rat anti-VECD (BD555289,
1:200), mouse anti-GM130 (BD610822, 1:100), rabbit anti-panAkt
(Cell Sig No. 9272, 1:200), and rabbit anti-p-eNOS-S1176 (Cell Sig
No. 9571, 1:200). Images were acquired using a Leica SP5 confocal
microscope with the Leica Application Suite software. Images reflect
a z-stack compression of the endothelial layer using the sequential
scan mode with an HCX PL APO λ blue 63×/1.40 oil objective.

17

The HLI model was performed, as previously described.23,24 In brief,
the left femoral artery and the proximal portion of the saphenous
artery are exposed, ligated, and excised. Ischemic and nonischemic
limb perfusion is measured pre-, post-surgery, 1-, 2-, 3-, and 4-weeks
after surgery using Laser Doppler scanning (LDI; Moor Instruments
Ltd). Perfusion data are analyzed and reported as a ratio of flow in
the injured relative/contralateral leg values. S-Nitroso-N-acetyl-DL
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penicillamine was injected locally (1 mg/mL, 30 μL injection) where
indicated before Laser Doppler scanning and flow measurements.

Micro-CT Imaging
Two-dimensional micro-CT scans were obtained using a GE eXplore
MS Micro-CT System, as previously described.23 Mice were administered 2% adenosine before delivery of the contrast agent to dilate the
vascular bed and definitively assess the effects on anatomy and vascular remodeling rather than vascular tone. Vessel density analyses were
performed on captured images, as previously described.23

Statistical Analysis
All data are shown as mean±SEM. Statistical significance was determined based on a P value calculation of P<0.05, where all comparisons reflect a 2-way ANOVA, Bonferroni analyses.

Results
Inducible Deletion of Adult
Endothelial Akt1 Expression
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Although viable, global Akt1-null mice exhibit significant neonatal mortality and are substantially smaller than WT littermate
controls.14,15 Therefore, we used an inducible, tissue-specific
approach to bypass potential retardation effects during gestation/growth as a result of global Akt1 loss. Inducible, endothelial-targeted (Cdh5-Cre-ERT2) Akt1 mice were generated using
Cre-loxP technology, as described previously.11 Young adult
mice (≈4–5 weeks of age) were administered tamoxifen for 7
consecutive days via intraperitoneal injection for adult phenotyping at ≈10 to 12 weeks of age (Figure IA in the online-only
Data Supplement). Whereas global Akt1 deletion yields significantly smaller mice, inducible deletion does not affect total
body weight (Figure IB in the online-only Data Supplement),
thereby eliminating body mass as a variable. En face wholemount immunofluorescent imaging of the endothelial layer
from various arterial vessels indicates near-complete ablation of
total Akt1 protein expression (Figure II in the online-only Data
Supplement), thus validating the inducible deletion strategy. The
Akt antibody was determined to be specific, as immunofluorescent labeling is undetectable in the endothelium of global Akt1
knockout mice (Figure III in the online-only Data Supplement).

Endothelial Akt1 Deletion Attenuates Ang1- and
PDGF-Stimulated eNOS Phosphorylation
Akt1 is the major isoform in the endothelium necessary for
mediating proangiogenic signaling events13 and has been demonstrated by several groups as a major kinase for eNOS phosphorylation and subsequent eNOS activation.3,4,10,25 Therefore,
we sought to assess eNOS function using an ex vivo approach to
validate the endothelial-targeted Akt1 knockout mouse model.11
In brief, segments of the thoracic aorta were isolated from adult
Akt1iECKO mice along with respective littermate controls and
incubated with Ang1, a prototypical PI3K/Akt agonist to induce
eNOS phosphorylation on S1176.26–29 The phospho-eNOS
antibody was determined to be specific for S1176, as immunofluorescence labeling detected phospho-eNOS-S1176 signal
in control vessels but not in vessels isolated from mice harboring a loss-of-function mutation in the Akt phosphorylation
site (eNOS-S1176A mice6; Figure IV in the online-only Data
Supplement). As seen in Figure 1A and 1B, en face staining

for phospho-eNOS-S1176 demonstrates enhanced perinuclear
phospho-eNOS levels30 in response to acute Ang1 treatment,
where this effect is significantly reduced in Akt1iECKO mice.
We similarly stimulated vessels with PDGF-BB, a potent growth
factor that activates Akt in the endothelium and induces endothelium-dependent relaxation in intact vessels.31,32 PDGF-BB
treatment of control aortas induces eNOS phosphorylation, thus
corroborating previous observations where PDGF-BB treatment
produced NO-mediated vessel relaxation,32 as endothelial-specific Akt1 deletion reduces eNOS-S1176 phosphorylation levels
(Figure VA in the online-only Data Supplement and quantified
in Figure VB in the online-only Data Supplement).

Endothelial Loss of Akt1 Decreases
NO Bioavailability
The transfer of eNOS-derived NO to hemoglobin in circulating erythrocytes relies on the diffusional distance and serves as
a critical determinant of plasma NO bioavailability.33 Thus, the
formation of Hb-NO is directly proportional to the amount of
bioavailable NO.34 Because of the stable nature of Hb-NO under
anaerobic conditions, Hb-NO levels measured by electron paramagnetic spin resonance techniques in isolated mouse blood35
reflect eNOS-derived NO levels in blood. Therefore, we measured Hb-NO levels in Akt1iECKO adult mice to determine
whether the loss of endothelial Akt1 affected NO bioavailability
(Figure 1C). Venous whole blood was collected from adult mice,
and Hb-NO was measured using electron paramagnetic spin resonance, as previously described.18 Genetically modified eNOS
mutant mice either mimicking (S1176D) or lacking (S1176A)
eNOS phosphorylation6 were additionally assessed together with
eNOS knockout as thresholding controls to determine the window of detection. All mice were given standard chow and food
restricted overnight to ensure fixed levels of nitrate/nitrite content to prevent dietary influences on NO bioavailability measurements. Although higher than the loss-of-function eNOS-S1176A
mutant, Akt1iECKO mice show significantly less Hb-NO in
blood compared with WT littermate controls, highlighting the
importance of the Akt1–eNOS axis in regulating NO bioactivity.

Endothelial Loss of Akt1 Decreases Basal NO
Levels and Impairs Vascular Function
Ex vivo examination of adult Akt1iECKO aortas clearly demonstrates blunted levels of eNOS phosphorylation. To test the
significance of these findings in intact vessels, myography
was used to examine vascular function in aortic rings from
Akt1iECKO mice. Aortic rings isolated from both control
and Akt1iECKO adult mice were subjected to various agonists, and tension–response curves were generated. Typical
contraction and relaxation responses were observed in control mice, with an EC50 for phenylephrine and acetylcholine
matching previously reported values36 (Figure 2A and 2B).
However, aortic rings from Akt1iECKO mice had increased
sensitivity to the contractile actions of phenylephrine and
KCl (Figure 2A and 2C), where pre-incubation of vessels
with the NOS inhibitor, l-NAME, normalized the phenylephrine response in Akt1iECKO mice (Figure 2D). This response
suggests that tension-induced release of NO, or basal NO
production, was impaired in vessels from Akt1iECKO mice.
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Figure 1. Endothelial loss of Akt1 impairs stimuli-induced eNOS (endothelial nitric oxide synthase) phosphorylation and decreases NO
bioavailability. A, Isolated thoracic aorta segments from Akt1iECKO mice display decreased phospho-eNOS S1176 when treated with
Ang1 (angiopoietin-1) ex vivo, quantified in (B). C, Less hemoglobin-bound NO (NO-Hb) levels were detected in peripheral blood of
Akt1iECKO adult mice when assessed by electron paramagnetic spin resonance (EPR) techniques. eNOS mutant (S1176D and S1176A)
and global eNOS knockout (KO) mice were used as gating controls for NO-Hb levels. The number of mice for each genotype shown as
indicated. All data are mean+SEM, n=3 to 6 mice per group, 2 to 6 images per mouse. *P<0.05, **P<0.01. AU indicates arbitrary units;
p-eNOS, phospho-eNOS; VECD, VE-cadherin; and VEH, vehicle.

Acetylcholine-dependent vessel relaxation in conduit vessels
occurs primarily through the release of endothelial-derived
NO.37 Interestingly, acetylcholine-mediated reductions in vascular tone were virtually indistinguishable between the groups
(Figure 2B), demonstrating that endothelial Akt1 is not critical for acetylcholine-mediated NO production, which occurs
primarily through Ca2+/CaM-dependent mechanisms.2,38

Endothelial-Specific Loss of Akt1 Significantly
Increases Diastolic Blood Pressure
Arterial pressure is of particular importance in maintaining vascular function and response, relying heavily on
shear stress–mediated endothelial NO production.39 The
observed decrease in eNOS phosphorylation and circulating Hb-NO together with the increased sensitivity to phenylephrine suggests that overall systemic blood pressure

may be affected in Akt1iECKO mice. Therefore, arterial
blood pressure and heart rate were monitored in intact,
conscious mice for over 72 hours using implanted telemetry devices.40 Akt1iECKO mice display elevated diastolic
pressures independent of the time of day (Figure 3A and
3B) and an associated inclination toward increased mean
arterial pressures (Figure VIA in the online-only Data
Supplement). Previous studies using similar telemetrybased blood pressure measurements in global Akt1KO mice
report nonsignificant trends toward increased arterial pressure,41 thus denoting the Akt1iECKO phenotype as the first
report of hypertension resulting from Akt1 impairment.
Other parameters, such as systolic blood pressure, heart
rate, and activity levels, were comparable between control
and adult Akt1iECKO mice (Figure 3C and 3D; Figure VIB
in the online-only Data Supplement).
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Figure 2. Basal NO production in vessels requires endothelial Akt1. A, Aortic rings from Akt1iECKO display increased sensitivity to phenylephrine (PE)-induced constriction, whereas (B) acetylcholine (Ach)-induced vascular relaxation is maintained, suggesting basal impaired
NO production in Akt1iECKO mice. Aortic rings from Akt1iECKO mice display enhanced (C) KCl-induced (60 mmol/L) constriction, where
(D) pre-incubation of vessels with l-NAME normalizes the differences in PE sensitivity. Data are mean±SEM, n=4 to 9 mice per group, 3 to
4 aortic rings per mouse. **P<0.01, ***P<0.001.

Endothelial Loss of Akt1 Results in
Impaired Blood Flow Recovery and
Decreased Arteriogenesis on HLI
In a model of HLI, the global loss of PI3Kγ42 or Akt110
results in critical limb ischemia and limb loss concomitant
with marked impairment in arteriogenesis and angiogenesis.
Nevertheless, the observed defects in global Akt1-deficient
mice likely reflect a complex response, involving multiple
cells types (eg, EC, SMC, macrophages), all of which express
the Akt1 isoform. We first assessed baseline arterial density
in the EC-inducible Akt1 deletion model using a phase contrast agent together with micro-CT imaging. Arterial vessels
were maximally dilated to definitively assess the vascular
network rather than vascular tone, where quantification did
not indicate any underlying deficits in artery number before
hindlimb injury between both groups (data not shown). We
subsequently performed the HLI model in Akt1iECKO and littermate controls to assess the role of EC-specific Akt1 expression in this injury response. In brief, the left femoral artery
was ligated and removed, on which blood flow is measured
over time using Laser Doppler imaging. Perfusion rates in the

surgically manipulated leg were normalized to the uninjured
contralateral limb for blood flow quantification. In control
mice, an acute decrease in blood flow was followed by progressive recovery of flow over 28 days post-injury. In contrast,
flow recovery in Akt1iECKO was significantly impaired by 14
days and persisted to 28 days post-ischemia when compared
with littermate controls (Figure 4A and 4B). To assess arterial
density after injury, micro-CT imaging was conducted 14 days
post-HLI.43 Micro-CT analyses indicate a significant decline
in the number of smaller arteries both above and below the
knee in Akt1iECKO mice post-ischemia (Figure 4C through
4E), suggesting that collateral remodeling and the development of new arterial branches was impaired by the loss of the
Akt1 isoform in ECs.
To reinforce the importance of Akt1-mediated eNOS
activation for vascular recovery, a rescue experiment was
performed using S-Nitroso-N-acetyl-DL-penicillamine,44 as
an NO donor. Global Akt1 knockout mice were used for rescue experiments because the deficit in blood flow after HLI
is much larger compared with reduced flow recovery in the
Akt1iECKO mice.10 As seen in Figure VII in the online-only
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Figure 3. Adult, endothelial-specific loss of Akt1 significantly increases diastolic BP. A, Telemetry readings indicate an elevated diastolic
pressure in free-roaming, conscious Akt1iECKO mice. The increase occurred during the diurnal cycle (B). The loss of Akt had no effect
on systolic pressure, (C) or heart rate (D), Data are mean±SEM with n=6 mice per group. **P<0.01, ***P<0.001. Graphs illustrate a 3-day
reading period where white and gray regions indicate light and dark cycles, respectively.

Data Supplement, administration of S-Nitroso-N-acetyl-DL
penicillamine with a single-injection downstream of the injury
site resulted in near immediate flow recovery in the injured
limb of control mice, with even greater flow increases in
global Akt1 knockout mice. The timely increase in blood flow
suggests the presence of a remodeled, yet dysfunctional and
constricted vasculature in global Akt1 knockout mice, where
eNOS activation may be critical for injury resolution through
both neovessel formation and vasomotor tone regulation.

Discussion
Akt1 controls many signaling pathways that regulate cell
survival, morphogenesis, and growth.7 Although global Akt1null mice have been instrumental in elucidating the in vivo
biological role of Akt1, the contribution of Akt1 signaling
from a cell-specific perspective has only recently begun to be
explored.11,16,45–47 Here, we show that endothelial loss of Akt1
using an inducible, postnatal EC-specific strategy results in
spontaneous hypertension, decreased NO bioavailability, and
impaired recovery to tissue limb ischemia—all indicative of
impaired NO production. These data are surprising given that
eNOS can be phosphorylated on S1176 in vitro by several

kinases including other AGC kinases (protein kinase A, G,
C) and AMPK.48 The Akt1iECKO phenotypes indicative of
impaired NO production suggest that physiologically, eNOSS1176 phosphorylation in vivo through Akt1 is crucial for NO
tone and blood pressure control.
A common feature of endothelial dysfunction is diminished NO bioavailability, where eNOS knockout mice are an
extreme state of NO deficiency.1 Regardless of the methodology used for blood pressure measurements, eNOS knockout mice are consistently hypertensive19,49–52 and display an
associated increase in cardiac mass and function.52 Akt1 has
been well established as a major kinase for eNOS phosphorylation3,4,6 and manipulation of Akt activity in vivo through
use of viral transfection methods in combination with arterial
flow measurements indicate that short-term hyperactivation of
Akt1 results in augmented NO release, enlarged vessel diameter, and enhanced blood flow.53 In addition, EC-specific transgenic expression of Akt1 increases NO production and reduces
injury-induced neointima formation.54 Although global Akt1
knockout mice present phenotypes similar to eNOS knockout, such as decreased homozygote offspring number and
reduced adult body weight,14,19 global Akt1 knockout mice are
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Figure 4. Endothelial loss of Akt1 results in impaired blood flow recovery on femoral artery ligation and reduced arteriogenesis. A, Endothelial-specific loss of Akt1 results in impaired blood flow recovery in response to hindlimb ischemia (HLI) 14 days post-ischemia. Relative blood flow perfusion ratio shown in (B). C, Arterial phase micro-CT analyses at 14 days post-injury indicates significant reduction in
small arteries/arterioles in thigh (D) and calf (E) regions in Akt1iECKO mice. Data are mean±SEM, with n=5 to 6 mice per group. *P<0.05,
**P<0.01, ***P<0.001.

not hypertensive.11,41 Normal blood pressures in global Akt1
knockout mice suggest that other kinases may regulate eNOS
or that the global loss of Akt1 promotes compensation by other
expressed Akt isoforms given the significant overlap in substrate specificity for Akt1 versus Akt2 in the endothelium.11
Thus, the hypertensive phenotype in adult Akt1iECKO mice
emphasizes the importance of the endothelial Akt1–eNOS
axis in vivo6 and suggests that adaptive changes likely occur
during development that preclude an obvious blood pressure
phenotype in global Akt1 knockout mice.
Moreover, cardiac output rates derived from echocardiography measurements did not indicate any differences between Akt1iECKO and littermate controls (data
not shown). Given the direct relationship between blood
pressure and peripheral resistance, the observed pressure

elevation together with the lack of change in cardiac output
suggests that the Akt1iECKO mice likely exhibit increased
systemic vascular resistance. Although smaller resistance
arteries have been conventionally reliant on endotheliumderived hyperpolarizing factor as the predominant mediator of vascular tone regulation, the recent discovery of
Hbα (hemoglobin α) in the myoendothelial junctions of
resistance arteries suggests a role for NO scavenging.55
The localized nature of Hbα at the myoendothelial junction may serve as a chelator of eNOS-derived NO to favor
endothelium-derived hyperpolarizing factor activity while
maintaining control over NO levels. Previous groups have
also shown the importance of eNOS expression on peripheral vascular tone, as partial deletion of eNOS increases
coronary vascular tone56 and pulmonary resistance,57 hence
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complementing the impaired vascular tone seen in isolated
vessels from Akt1iECKO mice (Figure 2).
Vascular remodeling occurs in both development and
under adult pathological conditions, requiring various adaptations in response to the physiological environment and pathological stimuli. Angiogenesis denotes the de novo formation
of capillaries from preexisting postcapillary venules and is
largely initiated by hypoxic events, whereas arteriogenesis
denotes the remodeling of preexisting collaterals or arterioles/capillaries, which is generally ischemia independent
and driven through hemodynamic and inflammatory factors
(ie, shear stress, wall tension).58,59 In experimental models of
HLI, arteriogenesis is stimulated through a marked increase
in fluid shear stress in arterial conduit vessels, providing a
driving force to promote collateralization.60 In the distal lower
limb, vascular remodeling is primarily mediated through tissue ischemia, resulting in the upregulation of several growth
factors critical for vascularization. eNOS-derived NO serves
as a naturally occurring, compensatory mechanism to regulate hemodynamic changes in both normal and ischemic tissues.61 eNOS function is also essential for native collateral
formation, immediate flow recovery post-ligation, and cellular recruitment in the remodeling vasculature—all of which
are critical for efficient arteriogenesis.62,63 The defective flow
recovery in adult Akt1iECKO mice herein likely reflects the
combinatorial effects of impaired eNOS-derived NO generation given the established role of the Akt1 kinase in eNOSS1179 phosphorylation.6 However, the impairment in blood
flow and arteriogenesis in Akt1iECKO mice is markedly
less than that observed in global Akt1 knockout10 or eNOS
knockout mice,64 implying that other kinases may contribute
to eNOS activation under these conditions or that expression
of Akt1 is also critical in SMCs and macrophages for proper
ischemic injury repair.
Recent work using conditional EC-specific Akt1 deletion mice has shown that the Akt1 isoform is necessary for
developmental retinal angiogenesis through regulation of EC
proliferation and survival,11 2 well-described functions of Akt
and downstream substrate phosphorylation. Furthermore,
the global deletion of Akt2 in combination with EC-specific
deletion of Akt1 did not further impair the developing retinal vasculature. In contrast, deletion of endothelial Akt1 in
adult mice had a mild effect on cardiac arteriogenesis (quantified via micro-CT), and this effect was markedly exacerbated
by the global deletion of Akt2,45 implying functional redundancy of these isoforms in the adult coronary vasculature.
Mechanistically, the loss of both isoforms in EC, and Akt2 in
smooth muscle, reduce endothelial expression of the Notch
ligand, Jagged1, thereby impairing Notch-Jagged regulation
of vascular stability. The means by which Akt as a kinase
regulates this pathway are not clear, as an Akt substrate has
not yet been identified to explain the reduced Jagged1 levels. Prior work has shown that Akt2 exerts a more prominent
role in determining vascular SMC phenotype and function.65,66
Global Akt2 knockout mice are additionally more susceptible
to aortic aneurysms,67 further demonstrating a role for the
Akt2 isoform in vascular tone regulation and vessel compliance through an NO-independent pathway. Nevertheless, our

studies indicate that in vivo eNOS activity is mediated primarily through the endothelial expression of Akt1 where postnatal deletion results in defects consistent with decreased NO
bioavailability.
Collectively, our data support the importance of the
Akt1–eNOS signaling axis in intact endothelium given its
primary role in NO production and vasomotor tone regulation. Akt1iECKO mice display phenotypes indicative of
NO insufficiency as seen through impaired agonist-induced
eNOS phosphorylation, blunted endothelial NO production
in vivo, diastolic hypertension, and defects in postischemic
arteriogenesis. Hence, PI3K-Akt1-NO signaling in EC is
critical for vascular tone regulation and adaptive vessel
remodeling.
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• Endothelial-specific Akt1 ablation in adult mice results in spontaneous hypertension.
• Adult, inducible, endothelial-targeted Akt1 deletion results in decreased NO bioavailability.
• Endothelial loss of Akt1 signaling impairs injury-induced arteriogenesis, indicative of impaired endothelial nitric oxide synthase function.

